Global News

Icon appoints Professor Brendan Buckley chief medical officer

Tuesday, July 9, 2013 10:33 AM

Global CRO Icon has appointed professor Brendan Buckley chief medical officer. Professor Buckley will be Icon’s lead medical expert, representing the company’s position on scientific, ethical and medical governance matters and provide guidance and oversight to the medical and scientific groups across Icon.

More... »

Evotec to close Indian chemistry operations

Monday, July 8, 2013 02:19 PM

Hamburg, Germany-based Evotec will close its chemistry operations in Thane, India. All chemistry work now will be performed at its Abingdon, U.K., facility, to address to an increasing requirement to operate closer to the principal R&D laboratories of major customers. All project work in Thane will be completed by the end of September, and Evotec (India) Private will then wind down.

More... »

E.U.-funded consortium to develop personalized brain cancer vaccines

Monday, July 8, 2013 12:09 PM

A project supported by a $7.7 million European Union Framework 7 (EU FP7) program grant to develop a novel class of therapeutic cancer vaccines is underway.

More... »

Novartis, Biological E partner to deliver affordable vaccines to developing world

Monday, July 8, 2013 12:07 PM

Novartis has entered into a development and licensing agreement with Biological E (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.

More... »

Avanir, OptiNose in licensing deal

Wednesday, July 3, 2013 02:13 PM

Avanir Pharmaceuticals and OptiNose have entered into an exclusive North American license agreement for the development and commercialization of OptiNose's novel Breath Powered intranasal delivery system containing low-dose sumatriptan powder to treat acute migraine. If approved, this product would be the first dry-powder nasal delivery form of sumatriptan.

More... »

Janssen, J&J Innovation ally with The Icahn School Of Medicine at Mount Sinai

Wednesday, July 3, 2013 12:30 PM

Janssen Biotech and Johnson & Johnson Innovation have established a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease (IBD) and the discovery of next generation therapeutic solutions.

More... »

Seattle Genetics, Agensys to co-develop ADC

Wednesday, July 3, 2013 09:30 AM

Seattle Genetics has exercised an option to co-develop an additional antibody-drug conjugate (ADC) under an existing ADC collaboration agreement with Agensys, an affiliate of Tokyo-based Astellas Pharma. The ADC, called ASG-15ME, targets the tumor antigen SLITRK6, which is expressed on bladder and lung cancer.

More... »

Pistoia Alliance launches HELM toolkit through open source license

Wednesday, July 3, 2013 09:00 AM

Global nonprofit Pistoia Alliance released the HELM (Hierarchical Editing Language for Macromolecules) biomolecular representation standard software toolkit and editor under the permissive open source MIT license.

More... »

Brett Davis named Deloitte Health Informatics general manager

Wednesday, July 3, 2013 08:53 AM

Brett J. Davis has been named general manager of Deloitte Health Informatics (DHI), a newly launched business providing advanced analytics services and products to healthcare providers, researchers and medical manufacturers’ managers.

More... »

Roche, AstraZeneca launch early research data-sharing consortium

Tuesday, July 2, 2013 01:24 PM

Roche and AstraZeneca are collaborating to share early research data related to drug design to further accelerate discovery of high-quality compounds with an increased chance of clinical success.

More... »